Slashdot Mirror


SCO Backing Off Linux Invoice Plan

rocketjam writes "CNet is reporting that the SCO Group is backing off plans to send invoices to corporate users in an effort to generate more takers of their Linux licensing plan. A spokesman said SCO executives were happy with current progress in the licensing program, and didn't feel they needed to send out invoices yet. SCO also extended the 'introductory' licensing price to the end of October, at which point the amount they are asking will double. Despite SCO's threats, 84 per cent of CIOs in a recent survey said it hasn't affected their plans to implement Linux."

4 of 283 comments (clear)

  1. Thank God! by ExCEPTION · · Score: 1, Funny

    I was so freaked out when I missed the introductory licensing dead line. Got to go to the bank now.

  2. mark -6 for redundant by netnerd.caffinated · · Score: 2, Funny

    I can't wait for this whole SCO thing to go away. Maybe it's a bit like that simpsons halloween episode where the billboard ads come to life. If you ignore them. They'll go away.
    SCO died because of Linux. They thought they were the only intel based Unix OS out there. They didn't innovate & they died.

    --


    You tried your best, & you failed miserably,
    The lesson is:
    Never Try
  3. phew! by pergamon · · Score: 2, Funny

    boy, am i relieved! i was getting really worried there for a while.

    no... no wait... no, actually, my policy is still that they can kiss my ass. yeah, that's it. sometimes i forget my policy on that.

  4. 499 out of Fortune 500 say no? McSCOre? by PB8 · · Score: 2, Funny

    So basically we can say 499 out of 500 Fortune 500 companies don't feel any need to pay SCO for the use of Linux after all of SCO's PR work.

    People have guessed Microsoft as the Forture 500 company. There's an alternative option. SCO has a large customer that's no small fry.

    Some know that McDonald's uses SCO at their cash registers for POS. Perhaps SCO managed to sell them Linux licenses in exchange for other favorable treatments.